Review paper
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
Volume: 47, Issue: 5, Pages: 1817 - 1828
Published: Apr 8, 2019
Abstract
The heart is one of the organs most vulnerable to sepsis. This review describes the general characteristics of sepsis-induced cardiomyopathy and the main pathogenesis of myocardial dysfunction in sepsis. Levosimendan is a novel drug for treatment of sepsis-induced myocardial dysfunction. This review also elaborates on the pathogenesis of levosimendan, including the mechanisms of its anti-inflammatory effects, improvement of myocardial ischaemia,...
Paper Details
Title
Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application
Published Date
Apr 8, 2019
Volume
47
Issue
5
Pages
1817 - 1828
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History